tirzepatide for nash in Consistent improvements liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with The percentage of participants who – Tirzepatide for Weight Loss (Fat

They love this idea because it: Reduces polypharmacy Reduces cost Reduces adverse drug events Improves life quality for those with apnea and diabetes They conclude, We strongly advocate for increased and early use of GLP-1 agonists in obstructive sleep apnea patients with co-occurring diabetes and other cardiometabolic conditions common in obstructive sleep apnea. They start with defining obstructive sleep apnea

It works by reducing appetite, slowing digestion, and enhancing feelings of fullness

Feng, A

Instead of using chemically engineered GLP-1RAs, alternative therapies could boost the bodys own GLP-1 production, for example, in pancreatic alpha cells